The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Barrowcliffe Susan E. since 2016.
The trader's CIK number is 1664251.
At the time of the last reporting, Barrowcliffe Susan E. was the General Manager, Europe of Aimmune Therapeutics, Inc.. (stock ticker symbol AIMT).
Also see all insider trading activities at Aimmune Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | AIMT | 0 | $0 | 115,000 | $4,011,100 | 115,000 | $347,528 |
| 2017 | AIMT | 0 | $0 | 60,000 | $1,353,945 | 60,000 | $181,317 |
| 2016 | AIMT | 0 | $0 | 35,000 | $800,000 | 35,000 | $105,769 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-11-19 | AIMT | Option Ex | 40,000 | 3.02 | 120,879 |
| 2018-11-19 | AIMT | Sale | 40,000 | 30.04 | 1,201,600 |
| 2018-01-02 | AIMT | Option Ex | 75,000 | 3.02 | 226,649 |
| 2018-01-02 | AIMT | Sale | 75,000 | 37.46 | 2,809,500 |
| 2017-09-25 | AIMT | Option Ex | 20,000 | 3.02 | 60,439 |
| 2017-09-25 | AIMT | Sale | 20,000 | 25.00 | 500,000 |
| 2017-09-06 | AIMT | Sale | 15,167 | 22.00 | 333,704 |
| 2017-09-05 | AIMT | Sale | 3,223 | 22.00 | 70,906 |
| 2017-09-06 | AIMT | Option Ex | 15,167 | 3.02 | 45,834 |
| 2017-09-05 | AIMT | Option Ex | 3,223 | 3.02 | 9,739 |
| 2017-07-27 | AIMT | Option Ex | 500 | 3.02 | 1,511 |
| 2017-07-27 | AIMT | Sale | 500 | 22.00 | 11,000 |
| 2017-07-21 | AIMT | Option Ex | 960 | 3.02 | 2,901 |
| 2017-07-21 | AIMT | Sale | 960 | 22.00 | 21,120 |
| 2017-07-24 | AIMT | Option Ex | 500 | 3.02 | 1,511 |
| 2017-07-25 | AIMT | Option Ex | 4,650 | 3.02 | 14,052 |
| 2017-07-24 | AIMT | Sale | 500 | 22.00 | 11,000 |
| 2017-07-25 | AIMT | Sale | 4,650 | 22.00 | 102,300 |
| 2017-07-03 | AIMT | Sale | 15,000 | 20.26 | 303,915 |
| 2017-07-03 | AIMT | Option Ex | 15,000 | 3.02 | 45,330 |
| 2016-11-11 | AIMT | Option Ex | 20,000 | 3.02 | 60,439 |
| 2016-11-11 | AIMT | Sale | 20,000 | 25.00 | 500,000 |
| 2016-11-08 | AIMT | Option Ex | 15,000 | 3.02 | 45,330 |
| 2016-11-08 | AIMT | Sale | 15,000 | 20.00 | 300,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Barrowcliffe Susan E. (General Manager, Europe of Aimmune Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.